Veterinary Medicines

Scanoporc EC/LT/CP -inaktywowane bakterie Escherichia coli serotyp O138:F18: nie mniej niż 10^9;-inaktywowane bakterie Escherichia coli serotyp O8:K88: nie mniej niż 10^9;-inaktywowane bakterie Escherichia coli serotyp O9:987P: nie mniej niż 10^9;-inaktywowane bakterie Escherichia coli serotyp O101:K99,F41: nie mniej niż 10^9;- toksoid LT E.coli: nie mniej niż 5 mg;-inaktywowane bakterie Clostridium perfringens typ C, ATCC 3628: nie mniej niż 7,5x10^8;-B-toksoid Cl. perfringens typ C, ATCC 3628: nie mniej niż 10 j.m. Zawiesina do wstrzykiwań

Authorised
  • Clostridium perfringens, type C, strain ATCC 3628, alpha toxoid
  • Clostridium perfringens, type C, strain ATCC 3628, Inactivated
  • Escherichia coli, LT toxoid
  • Escherichia coli, serotype O138 (fimbrial adhesin F18), Inactivated
  • Escherichia coli, serotype O101:K99 (fimbrial adhesin F5), Inactivated
  • Escherichia coli, serotype O8:K88, Inactivated
  • Escherichia coli, serotype O9 (fimbrial adehsin F6), Inactivated
Download as PDF

Product identification

Medicine name:
Scanoporc EC/LT/CP -inaktywowane bakterie Escherichia coli serotyp O138:F18: nie mniej niż 10^9;-inaktywowane bakterie Escherichia coli serotyp O8:K88: nie mniej niż 10^9;-inaktywowane bakterie Escherichia coli serotyp O9:987P: nie mniej niż 10^9;-inaktywowane bakterie Escherichia coli serotyp O101:K99,F41: nie mniej niż 10^9;- toksoid LT E.coli: nie mniej niż 5 mg;-inaktywowane bakterie Clostridium perfringens typ C, ATCC 3628: nie mniej niż 7,5x10^8;-B-toksoid Cl. perfringens typ C, ATCC 3628: nie mniej niż 10 j.m. Zawiesina do wstrzykiwań
Active substance:
  • Clostridium perfringens, type C, strain ATCC 3628, alpha toxoid
  • Clostridium perfringens, type C, strain ATCC 3628, Inactivated
  • Escherichia coli, LT toxoid
  • Escherichia coli, serotype O138 (fimbrial adhesin F18), Inactivated
  • Escherichia coli, serotype O101:K99 (fimbrial adhesin F5), Inactivated
  • Escherichia coli, serotype O8:K88, Inactivated
  • Escherichia coli, serotype O9 (fimbrial adehsin F6), Inactivated
Target species:
  • Pig
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • Clostridium perfringens, type C, strain ATCC 3628, alpha toxoid
    10.00
    international unit(s)
    /
    1.00
    international unit(s)
  • Clostridium perfringens, type C, strain ATCC 3628, Inactivated
    750.00
    million organisms
    /
    1.00
    millilitre(s)
  • Escherichia coli, LT toxoid
    5.00
    milligram(s)
    /
    1.00
    milligram(s)
  • Escherichia coli, serotype O138 (fimbrial adhesin F18), Inactivated
    1000.00
    million organisms
    /
    1.00
    millilitre(s)
  • Escherichia coli, serotype O101:K99 (fimbrial adhesin F5), Inactivated
    1000.00
    million organisms
    /
    1.00
    millilitre(s)
  • Escherichia coli, serotype O8:K88, Inactivated
    1000.00
    million organisms
    /
    1.00
    millilitre(s)
  • Escherichia coli, serotype O9 (fimbrial adehsin F6), Inactivated
    1000.00
    million organisms
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Pig
  • Subcutaneous use
    • Pig
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI09AB08
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Poland
Available in:
  • Poland
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Scanvet Poland Sp. z o.o.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Laboratorios Ovejero S.A.
Responsible authority:
  • URPL
Authorisation number:
  • 1780
Date of authorisation status change:
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."